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Abstract
Background: Portal vein arterialization (PVA) has been used as a salvage inflow technique when hepatic
artery (HA) reconstruction is deemed impossible in liver transplantation (LT) or hepatopancreatobiliary
(HPB) surgery. Outcomes and the management of possible complications have not been well described.
Methods: The present study analysed outcomes in 16 patients who underwent PVA during the period
from February 2005 to January 2011 for HA thrombosis post-LT (n = 7) or after liver resection (n = 1),
during curative resection for locally advanced HPB cancers (requiring HA interruption) (n = 7) and for HA
resection without reconstruction (n = 1). In addition, a literature review was conducted.
Results: Nine patients were women. The median age of the patients was 58 years (range: 30–72 years).
Recovery of intrahepatic arterial signals and PVA shunt patency were documented using Doppler ultra-
sound until the last follow-up (or until shunt thrombosis in some cases). Of five postoperative deaths, two
occurred as a result of haemorrhagic shock, one as a result of liver ischaemia and one as a result of
sepsis. The fifth patient died at home of unknown cause. Three patients (19%) had major bleeding related
to portal hypertension (PHT). Of these, two underwent re-exploration and one underwent successful
shunt embolization to control the bleeding. Four patients (25%) had early shunt thrombosis, two of whom
underwent a second PVA. After a median follow-up of 13 months (range: 1–60 months), 10 patients (63%)
remained alive with normal liver function and one submitted to retransplantation.
Conclusions: Portal vein arterialization results in acceptable rates of survival in relation to spontaneous
outcomes in patients with completely de-arterialized livers. The management of complications (especially
PHT) after the procedure is challenging. Portal vein arterialization may represent a salvage option or a
bridge to liver retransplantation and thus may make curative resection in locally advanced HPB cancers
with vascular involvement feasible.
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Introduction
A totally de-arterialized liver is an organ which, in addition to
hepatic artery (HA) ligation or resection, is subjected to the com-
plete interruption of all collateral sources of arterial inflow
(interlobar hepatic arteries, peribiliary plexus, collaterals in trian-
gular ligaments and lesser omentum).1–6 This may occur in
patients with HA thrombosis (HAT) after liver transplantation
(LT), in which a totally de-arterialized liver graft to which the HA
is the only arterial inflow vessel is implanted, and in some
instances of major liver resection which involve HA resection, in
which the liver is completely mobilized from its attachments and
skeletonization of the porta with division of the biliary tree is
performed in order to achieve oncological clearance.7,8 In these
situations, if the HA is not reconstructed, biliary ischaemia and
necrosis are inevitable, and liver necrosis and fatal liver failure are
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possible. However, ischaemic cholangitis and bile duct necrosis do
not occur in all patients with a de-arterialized liver. This may in
part reflect the rapid development of collaterals after the complete
interruption of the HA (as in some cases of late HAT9,10).
Portal vein arterialization (PVA) is a salvage technique used in
a de-arterialized liver to establish arterial inflow when all other
possible strategies for the reconstruction of the artery have been
ruled out.11 The procedure increases the oxygen saturation of
portal vein (PV) blood significantly, prevents hepatic necrosis
and insufficiency, and promotes liver regeneration.12,13 It will also
alleviate the ischaemic state of bile ducts because the terminal
PV tributaries form anastomoses with the arterial peribiliary
plexus.3,12,14
Reported experiences with PVA in completely de-arterialized
livers are limited and consist only of case reports or small series.
These do not detail the mid- or longterm outcomes of the
procedure or describe possible consequences, particularly in rela-
tion to the development of portal hypertension (PHT) and liver
fibrosis.
The aim of the present study was to evaluate results achieved
with salvage PVA in 16 patients in a single centre over a 6-year
period, with particular emphasis on longterm results. In addition,
the published literature was reviewed for relevant studies on the
utility of PVA and subsequent outcomes.
Materials and methods
Patient selection
Between February 2005 and June 2011, 16 patients with totally
de-arterialized livers in which HA reconstruction was impossible
underwent PVA at the Hepatobiliary Centre, Paul Brousse Hospi-
tal (Villejuif, France).
Portal vein arterialization was performed in the setting of LT
in seven patients (Table 1) and hepatopancreatobiliary (HPB)
surgery in nine patients (Table 2).
In the LT setting, all instances of PVA were performed in emer-
gency contexts for HAT. Four patients suffered early HAT that
occurred within the first 2 months after LT and three experienced
late HAT in which no arterial collateral inflow to the liver was
demonstrable at the time of presentation.
In the setting of HPB surgery, PVA was performed either in
an emergency (for HAT or HA injury) or as an elective procedure
for curative surgery in locally advanced malignancies. It was
performed immediately during resection for planned curative
surgery (involving HA resection as a result of tumour invasion) in
patients with HPB malignancy (n = 4), or during HA ligation for
multiple symptomatic arterial aneurysms (n = 1), or in response
to HA injury detected during surgery (n = 3), or as a salvage
procedure in the event of HAT (n = 1) after hepatectomy.
Surgical strategy
Salvage PVA was discussed only after Doppler ultrasound (US)
and a multidetector computed tomography (MDCT) angiogram
before planned surgery had confirmed the absence of intrahepatic
arterial signals and a patent PV. The absence of arterial signals was
reconfirmed using Doppler US in the operating room, as was
the non-feasibility of arterial reconstruction. During the study
period, the centre’s surgical team performed microvascular
surgery including arterial reconstructions (under the microscope)
in living related donor LT (>100 patients), split liver transplanta-
tion (>100 patients) and liver resection surgery (12 patients). The
decision to proceed with PVA was always taken only after all
options for arterial reconstruction (including microvascular
surgery) had been explored and were considered impossible.
The present group preferred to use the coeliac trunk, HA or
splenic artery (SA) as the inflow vessel, provided the operative
field was favourable (i.e. that it allowed for easy dissection and did
not feature severe adhesions or either proven or suspected local
infectious foci, such as a biliary fistula). In other situations, the
shunt was performed in the infra-mesocolic compartment using
different vessels as detailed in Tables 1 and 2. A palpable thrill on
the PV wall and a PVA-type intrahepatic PV flow pattern on
Doppler US were considered to indicate the successful creation of
the shunt. No prophylactic procedures for postoperative PHT,
such as PVA calibration, were performed. Perioperative mortality
was defined as mortality occurring within 3 months after PVA or
during the same hospitalization.
Postoperative assessment and longterm follow-up
The standard postoperative protocols for the follow-up of LT
recipients or liver resection patients were used. Doppler US was
performed daily in the intensive care unit (ICU) and twice weekly
once the patient had been moved to the ward to confirm the
patency of the PVA. Contrast CT angiography was performed
before discharge to check the patency of the shunt and/or collat-
eral inflow to the liver. No anticoagulation or anti-platelet treat-
ment other than that included within the normal post-LT protocol
was given.
After discharge, patients were examined for signs of PHT
[ascites or varices on upper gastrointestinal (GI) endoscopy],
abdominal pain, diarrhoea and encephalopathy. The patency of
the PVAwas confirmed on Doppler US and/orMDCT. This evalu-
ation was performed at 1, 3 and 6 months, and then yearly after
discharge.
Results
Operative details and the postoperative courses of all patients are
summarized in Tables 1 and 2. Portal vein arterialization was fea-
sible in all attempts.
Portal vein arterialization in the setting of LT
In the setting of LT (Table 1), the first four patients underwent
emergency PVA for early HAT. None had intrahepatic collaterals
on preoperative MDCT. Patients 1 and 2 had portal hypertensive
ascites in the postoperative period, which resolved spontaneously.
The PVA was patent in all patients until the last follow-up and
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there were no residual signs of PHT in the three patients who
remained alive with good liver function. On postoperative day
(PoD) 35 after initial LT, Patient 4 demonstrated thrombosis in the
Gore-Tex® interposition graft used for arterial reconstruction,
with no intrahepatic flow on MDCT and Doppler US. A PVA [left
colic artery to left colic vein, draining into the inferior mesenteric
vein (IMV)] was performed. The patient underwent three
re-laparotomies in the postoperative period for diffuse intra-
abdominal bleeding (clot evacuation and packing were per-
formed) in which no definite site of bleeding was identified. The
patient died 2 months after LT as a result of multi-organ failure
following haemorrhagic shock.
Three other patients presented with late HAT. Patients 5 and 6
presented with a GI bleed; on investigation both were found to
have developed an arterial graft-to-duodenal fistula. Patient 5 had
HA stenosis at 14 months after LT and underwent successful HA
stenting. Six months later, she had a GI bleed which was found to
have been caused by the erosion of the iliac artery graft (used for
arterial reconstruction during LT) into the duodenum. The bleed
was initially controlled by endoscopic clip application and adrena-
line injection. A covered stent placed in the iliac artery graft at the
site of the leak thrombosed within a few hours. An initial attempt
at thrombolysis also failed. No intrahepatic arterial signal was
detected. A left colic artery-to-ileocolic vein shunt was performed.
The shunt thrombosed after 5 days with no intrahepatic arterial
signal. The patient underwent a second PVA (right iliac artery to
middle colic vein using an interposition Gore-Tex® graft). Good
intrahepatic flow was demonstrated. This patient required
Table 1 Main characteristics of seven liver transplant patients submitted to portal vein arterialization (PVA) at Paul Brousse Hospital
Patient Age,
years/sex
Liver transplant or hepatobiliary surgery Portal vein arterialization
Indication for surgery Primary
procedure
Indication for PVA (timing) Type Interposed vein/prosthetic
graft used
1 60/M NASH-related cirrhosis DDLT HAT (2 days) RGEA to RGEV No
2 56/M Alcoholic cirrhosis with HCC DDLT HAT (39 days) HA to PV No
3 59/M Alcoholic cirrhosis DDLT HAT (17 days) → revascularization
→ re-HAT with biliary stricture
(77 days)
Left genital artery to IMV No
4 30/M HBV cirrhosis with HCC DDLT HAT (35 days) LCA to LCV No
5 30/F Secondary biliary cirrhosis Domino LT HAT with GI bleed (graft →
duodenal fistula) (20 months)
LCA to ICV
(first PVA)
No
6 65/M Haemochromatosis with HCC Domino LT HAT with GI bleed (graft →
duodenal fistula), false aneurysm
LHA (29 months)
RIA to SMV Yes
7 49/F Acute liver failure (paracetamol
poisoning)
DDLT HAT with biliary fistula (106 days)
→ revascularization → rupture of
HA at 130 days
RGEA to RGEV No
Patient Age,
years/sex
Postoperative course Delayed
complications
Survival outcomes
(follow-up period)
Cause of death
Significant
complications
PVA thrombosis/
manner of detection
Re-intervention
1 60/M Ascites,
encephalopathy
No No – Alive
(12 months)
–
2 56/M Ascites No No – Alive
(11 months)
–
3 59/M No No No Biliary stenosis
managed
successfully
with metallic
stent
Alive
(23 months)
–
4 30/M Intra-abdominal bleed
with haemorrhagic
shock
No Laparotomy with abdominal
packing for intra-abdominal
bleed
– Death
(71 days after
DDLT)
Haemorrhagic shock
with multi-organ
failure
5 30/F – Yes/detected on Doppler
imaging (5 days)
Second PVA (RCIA to MCV)
with interposition Gore-Tex®
graft
Recurrent
cholangitis:
retransplanted
Alive
(12 months)
–
6 65/M Intra-abdominal bleed
caused by extension
of and bleed from LHA
pseudoaneurysm
Yes/detected on Doppler
imaging (13 days)
Embolization of LHA
pseudoaneurysm
No re-PVA in view of good
collaterals
– Alive
(12 months)
–
7 49/F Cholangitis No Retransplantation at 8.5
months
– Death (10 months
after first DDLT)
Abdominal sepsis with
multi-organ failure
after re-LT
DDLT, deceased donor liver transplantation; F, female; GI, gastrointestinal; HA, hepatic artery; HAT, hepatic artery thrombosis; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; ICV,
inferior colic vein; IMV, inferior mesenteric vein; LCA, left colic artery; LCV, left colic vein; LHA, left hepatic artery; LT, liver transplant; M, male; MCV, middle colic vein; NASH, non-alcoholic
steatohepatitis; PV, portal vein; RCIA, right common iliac artery; RGEA, right gastroepiploic artery; RGEV, right gastroepiploic vein; RIA, right iliac artery; SMV, superior mesenteric vein.
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Table 2 Main characteristics of nine hepatopancreatobiliary surgery patients submitted to portal vein arterialization (PVA) at Paul Brousse
Hospital
Patient Age,
years/sex
Liver transplant or hepatobiliary surgery Portal vein arterialization
Indication for surgery Primary procedure Indication for PVA and timing Type Interposed
vein/prosthetic
graft used
8 36/F Intrahepatic
cholangiocarcinoma
Ex situ right extended
hepatectomy (including
segments I and IV) with partial
resection of segments II and III
For curative resection (contralateral
artery involvement)
CHA to PV No
9 61/M Hilar cholangiocarcinoma
(Klatskin type IIIB)
Left extended hepatectomy
(including segments I, V, VIII)
For curative resection (RHA
involvement)
CHA to PV No
10 57/M Gallbladder cancer with
invasion of PV, HA, CBD
Left extended hepatectomy
(including segment V)/PD,
resection and reconstruction of
PV, ligation of HA
For curative resection Aorta to IMV Yes
(6-mm Gore-Tex®)
11 40/F Schwannoma of hepatic
pedicle
Resection of schwannoma/PV/HA/
main bile duct PV reconstruction
with Gore-Tex® graft, HJ
For curative resection IMA to IMV No
12 70/F Multiple aneurysms coeliac
trunk to HA
Aneurysm resection/CHA + SA +
LGA ligation
CHA ligation for aneurysm CA to PV Yes
(6-mm Gore-Tex®)
13 46/F Large HCC in a non-cirrhotic
liver
RH (VE preserving the caval flow,
hypothermic perfusion)
HA injury with intraoperative
ligation (no arterial inflow to
remnant left liver)
SA to PV trunk with
IMA graft on PoD 1
Yes
14 72/F Synchronous colorectal liver
metastases with HA
infusion catheter in situ
(post-systemic
chemotherapy)
Left hepatectomy Intraoperative detection of
thrombosed RHA secondary to
HA catheter
ICA to IMV No
15 60/F Pancreatic adenocarcinoma Pancreaticoduodenectomy with PV
resection (for tumoral invasion)
Absence of arterial intrahepatic
flow on intraoperative Doppler
US
SA to PV with cadaveric
arterial iliac graft
No
16 67/F Pancreatic adenocarcinoma Pancreaticoduodenectomy with PV
resection (for tumoral invasion)
HAT (2 days) Aorta to IMV Yes
Patient Age,
years/sex
Postoperative course Delayed
complications
Survival outcomes
(follow-up period)
Cause of
death
Significant complications PVA thrombosis/
manner of detection
Re-intervention
8 36/F No Yes/transaminitis
(7 days)
Second PVA (aorta to MCV with
interposition graft)
– Died 29 days after
resection
Multi-organ
failure
9 61/M Massive ascites, four
episodes of variceal
bleed, hyperbilirubinaemia
(2 months)
No TAE of shunt caused by portal
hypertensive bleed
(2.5 months postoperatively)
– 13 months, lost to
follow-up
–
10 57/M Three episodes of
intra-abdominal bleeding
with haemorrhagic shock
No Multiple laparotomies with packing
and finally ligation of the shunt
as a result of recurrent
intra-abdominal bleeding
– Died at 14 days Haemorrhagic
shock with
multi-organ
failure
11 40/F Ascites, oesophageal
varices and portal vein
thrombosis at 3 months
No TAE of the shunt as a result of
portal hypertension at 4.5
months.
– Alive at 24 months –
12 70/F No Yes/transaminitis
(2 days)
No re-PVA in view of good
collaterals
– Alive at 12 months –
13 46/F No No No – Alive at 60 months –
14 72/F No No No – Alive at 12 months/
lymph node recurrence
–
15 60/F Ischaemic necrosis of the
right liver, lactic acidosis,
cardiac arythmia
No No – Died 3 days after
resection
Multi-organ
failure.
16 67/F No No TAE of the shunt ‘de principe’ at
40 days
Biliary fistula Died 2.5 months after
resection
NA
CA, coeliac artery; CHA, common hepatic artery; CBD, common bile duct; F, female; HA, hepatic artery; HAT, hepatic artery thrombosis; HJ, hepaticojejunostomy; NA, not available; IMA,
inferior mesenteric artery; IMV, inferior mesenteric vein; ICA, ileocolic artery; LGA, left gastric artery; M, male; MCV, middle colic vein; PoD, postoperative day; PV, portal vein; RH, right
hepatectomy; RHA, right hepatic artery; SA, splenic artery; TAE, transarterial embolization; US, ultrasonography; VE, vascular exclusion.
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retransplantation 5 months later as a result of recurrent ischaemic
cholangitis. She is presently doingwell. Patient 6,who presented 29
months after LT,underwent emergency surgerywith ligation of the
distal end of the iliac graft and overrunning of the bleeding duo-
denal ulcer.The arterial supply to the graft via the left hepatic artery
(LHA) was preserved. Two months later, a 2-cm pseudoaneurysm
was detected at the origin of the LHA in the absence of an
intrahepatic arterial flow signal. It was decided that arterial inflow
to the graft should be established via a PVA. An anastomosis
between the right iliac artery and superior mesenteric vein was
performed using an interposition Gore-Tex® graft (Fig. 1a, b). In
the postoperative period, the patient suffered an intra-abdominal
bleed with haemorrhagic shock. Angiography revealed that the
pseudoaneurysm had progressed proximally to the coeliac trunk.
Therapeutic embolizationwas performed.Onday 13 after thePVA,
a thrombosis of the interposed Gore-Tex graft was noted; however,
good collaterals, including hepatopetal flow and good intrahepatic
arterial flow signals, were observed. No further intervention was
carried out. The patient is doing well 12 months after the PVA.
Patient 7 developed a biliary fistula post-LT; later HAT was
detected on PoD 106. The graft was revascularized using a
saphenous vein graft conduit. However, 2 weeks later (PoD 130),
the patient exhibited intra-abdominal bleeding secondary to HA
rupture. An exploratory laparotomy with haemostasis, ligation of
the HA and a PVA (right gastroepiploic artery to vein anastomo-
sis) was performed. This patient required retransplantation at 8.5
months for ischaemic cholangitis. Postoperatively, he developed
intra-abdominal sepsis and died of multi-organ failure at 10
months after the first LT.
Portal vein arterialization in the setting of
HPB surgery
Immediate PVA (during surgery) after HA resection or
ligation for oncological clearance during curative surgery
In four patients (Patients 8–11), the HA was infiltrated by the
tumour and thus its resection was necessary to ensure curative
surgery (Table 2). Hepatic artery reconstruction after resection
was technically impossible and thus PVA was used to provide
arterial inflow to the remnant liver.
In Patient 8, the first PVA thrombosed; a second PVA was per-
formed with an interposition graft, but the patient died soon after
surgery as a result ofmulti-organ failure.ThePVA shuntwas patent
on Doppler US until just before the patient’s death. Patient 9
showed signs of PHT in the form of massive ascites and variceal
bleed after PVA; the PVA shunt was found to be embolized (Fig. 2).
This patient has since donewell and has demonstrated normal liver
function and no further sequelae of PHT. Patient 10, who had
undergone radical surgery for carcinoma of the gallbladder, sub-
mitted to three re-explorations for intra-abdominal bleeding and
haemorrhagic shock. The PVA shunt was ligated and packing
performed. However, the patient died at 14 days after the index
surgery as a result of multi-organ failure. In the postoperative
period, Patient 11 developed ascitis and endoscopy revealed grade
III oesophageal varices (non-bleeding). In addition, portal vein
thrombosis (PVT) that was well compensated by a large portal
cavernomawas detected at 3months after the indexprocedure.The
patient underwent an embolization of the PVA at 4.5 months as a
result of PHT.At 24months after resection, the patient continues to
progress and maintains normal liver function.
Immediate PVA for multiple arterial aneurysms
Patient 12 had idiopathic symptomatic aneurysms (severe
abdominal pain, fever, weight loss) of the coeliac trunk branches
including the common hepatic artery (CHA). Preoperative
imaging showed collateral pathways to the liver developed by way
of the pancreaticoduodenal arcades and the gastroduodenal
artery. The patient submitted to elective surgery in which the
ligation of all aneurysms was planned. After ligation of the CHA,
SA and left gastric artery, intraoperative Doppler US failed to
show intrahepatic arterial flow. The surgical team administered
local papaverine and waited an adequate length of time to rule out
(a) (b)
Figure 1 Portal vein arterialization for hepatic artery thrombosis post-liver transplantation in Patient 6, demonstrated as (a) an intraoperative
view and (b) in postoperative multidetector computed tomography showing the complexity of the arteriovenous shunt between the right iliac
artery (RIA) and the superior mesenteric vein (SMV) using an interposed Gore-Tex® [polytetrafluoroethylene (PTFE)] graft measuring 6 mm
in diameter
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spasm of the collateral hilar vessels. However, when no
intrahepatic arterial signals were detected, a PVA between the
coeliac trunk and PV using a Gore-Tex® prosthetic interposition
graft was performed (Fig. 3a–d). Shunt patency was demonstrated
by routine daily Doppler US until post-PVA day 7. Doppler US on
PoD 12 revealed a thrombosis of the PVA. However, good
intrahepatic arterial signals through collaterals were obtained and
hence no further intervention was performed. The patient’s liver
function stabilized and she was discharged from hospital on PoD
15. She continues to progress 1 year after the procedure.
Immediate PVA for HA injury during surgery or
intraoperative detection of HAT/no intrahepatic flow
on Doppler US
Portal vein arterialization was performed as an immediate salvage
procedure for HA injury or HAT detected during surgery in three
patients (Patients 13–15).
In Patient 13, a PVA was performed by creating a shunt between
the colic artery and colic vein intraoperatively because no arterial
flow in the remnant left liver was observed. On PoD 1, the patient
demonstrated raised levels of transaminases (>2000 IU/l) and
high arterial ammonia. In addition, some hypovascular areas of
ischaemia were noted in the remnant liver on CT scan, with no
intrahepatic arterial flow. The patient underwent an SA-to-PV
shunt using an interposition cadaveric internal mammary artery
(IMA) graft. The patient continues to do well at 5 years after the
index surgery and demonstrates shunt patency and no signs of
PHT.
Patient 15 underwent a pancreaticoduodenectomy with PV
resection (as a result of tumour involvement) for a pancreatic
adenocarcinoma. Intraoperatively, Doppler US revealed the
absence of good intrahepatic arterial signals. An SA-to-PV shunt
was created using a cadaveric iliac artery graft as a conduit. In the
postoperative period, the patient developed ischaemic necrosis of
the right liver, severe lactic acidosis and cardiac arrhythmias, and
died on day 3 after resection as a result of multi-organ failure.
Delayed PVA for HAT after HPB surgery
Patient 16 had undergone pancreaticoduodenectomy and PV
resection for a pancreatic adenocarcinoma. This patient devel-
oped HAT on PoD 2 and demonstrated transaminase levels of
>5000 IU/ml. A PVA was performed by anastomosing the aorta to
the IMV using an interposition Gore-Tex® graft. The patient pro-
gressed well in the immediate postoperative period, showing no
signs of PHT and no thrombosis of the shunt. A ‘de principe’
embolization of the shunt was performed at 40 days after the PVA.
The patient developed a biliary fistula, which was managed with
stenting. The patient died at home, 2.5 months after the resection,
of unknown causes.
Complications
There were five postoperative deaths among the patients in this
series. Two patients died as a result of haemorrhagic shock. One
patient died from liver ischaemia and one patient died from sepsis.
The fifth patient died at home of unknown cause.
In the present series, seven patients (44%) had some form of
PHT-related complication. Four patients developed significant
ascites in the postoperative period and three had significant bleed-
ing (either intra-abdominal or variceal). Two of these three
patients submitted to re-exploration with the aim of controlling
bleeding and one underwent successful radiological PVA shunt
embolization. Two of these patients died as a result of haemor-
rhagic shock.
Early PVA shunt thrombosis was documented in four (25%) of
the 16 patients. One patient from the LT group, who later required
a retransplantation for recurrent cholangitis, and one patient
(a) (b)
Figure 2 Computed tomography (CT) images in Patient 9, who underwent left hepatectomy extended to segments I, V and VIII for hilar
cholangiocarcinoma with arterioportal anastomosis between the hepatic artery and portal vein. (a) A CT angioscan at 5 days after portal vein
arterialization (PVA) shows the patency of the surgical shunt between the hepatic artery and the portal vein. (b) At 5 months after PVA, the
arteriovenous shunt is occluded by three concentric stents (white arrow) positioned in the hepatic artery because of recurrent episodes of
variceal bleeding
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from the HPB surgery group underwent re-PVA. The other two
patients were not submitted to re-PVA because good collateral
inflow had developed.
Therapeutic embolization or ligation of the arterioportal shunt
was performed in four patients (25%), either as an emergency
procedure in response to bleeding (n = 2) or electively (n = 2).
Two patients required retransplantation as a result of recurrent
cholangitis.
Two patients developed infective complications following PVA,
which included liver necrosis and cholangitis.
Discussion
In the present series of 16 patients submitted to PVA in a totally
de-arterialized liver, in a single study centre, the recovery of
intrahepatic arterial signals and PVA patency (or shunt thrombo-
sis or embolization in some patients) were documented until the
last follow-up using Doppler US and/or MDCT. After a median
follow-up of 13 months, 10 patients (63%) remained alive with
good liver function; one of these patients had undergone
retransplantation for recurrent cholangitis during this period.
Human PVA in a de-arterialized liver was first reported in 1992
by Iseki et al., who performed PVA in a patient in whom HA
ligation following arterial rupture and haemorrhage after a
Whipple procedure was required.11 Subsequently, the use of PVA
has been reported in LT and in HPB surgery primarily for HAT.
Incidences of early and late HAT after LT are estimated to be
around 4.4% and 1.7%, respectively.15,16 The natural history of
early HAT is massive liver necrosis and/or bile duct necrosis, fre-
quently followed by uncontrollable sepsis and, ultimately, death.15
Revascularization attempts are successful in only 50% of patients
because of the absence of a suitable inflow vessel, and urgent
re-LT, which may be considered the standard of care in such
patients, is not always possible because of the paucity of donors. In
late HAT, 55% of patients present with liver abscesses, 36% with
biliary tree necrosis and others with biliary complications such as
leak or fistula.16 In this scenario, even if re-LT is performed
immediately, the success rate is 50%, and deaths occur primarily
as a result of sepsis.16,17 Waiting for a suitable donor also delays a
re-LT. Portal vein arterialization has been used in the emergency
setting to re-establish arterial inflow to the liver when
thrombolysis by interventional radiology has failed and there is no
other option for the reconstruction of the HA. Usually, it serves as
a bridge to retransplantation and avoids the risk for massive
hepatic necrosis subsequent to the complete interruption of arte-
rial inflow. The patient can then be submitted to elective
(a) (b)
(c) (d)
Figure 3 Multidetector computed tomography (MDCT) with arterial contrast in Patient 12. (a, b) Preoperative images show the common
hepatic artery (thin white arrow) and coeliac trunk (thick white arrow) aneurysms. (c, d) Postoperative images with arterial contrast at 2 days
after the ligation of aneurysms and common hepatic artery ligation with portal vein arterialization show that (c) the arteriovenous shunt
between the coeliac trunk and the portal vein is thrombosed, but good collateral inflow is apparent, and (d) the collateral arterial supply to
the liver arises from the gastroduodenal artery
HPB 729
HPB 2014, 16, 723–738 © 2013 International Hepato-Pancreato-Biliary Association
Table 3 Use of portal vein arterialization (PVA) in portal vein thrombosis and auxiliary liver transplantation
Authors, year Age,
years
Liver transplantation Portal vein arterialization
Indication Procedure Indications Timing Type Interposed vein or
prosthetic graft
Erhard et al.
(1995)19
29 NA NA Post-LT PVT NA Recipient aorta to
graft PV (with
calibration)
Yes
Erhard et al.
(1995)19
47 NA NA Pre-LT PVT During LT Recipient aorta to
graft PV (with
calibration)
Yes
Aspinall et al.
(1996)26
53 Hepatitis B cirrhosis DDLT Post-LT PVT 2 days after LT Recipient aorta to
graft PV
Yes
Neelamekam et al.
(1997)20
55 Autoimmune chronic
hepatitis
DDLT Pre-LT PVT During LT Recipient HA to
graft PV
Yes
Erhard et al.
(1998)27
49 Acute liver failure Auxiliary LT – During LT NA NA
Erhard et al.
(1998)27
18 Acute liver failure Auxiliary LT – During LT Recipient iliac
artery to graft
PV
Yes
Erhard et al.
(1998)27
25 Acute liver failure Auxiliary LT – During LT NA NA
Erhard et al.
(1998)27
20 Acute liver failure Auxiliary LT – During LT Recipient iliac
artery to graft
PV
Yes
Margarit et al.
(2000)28
25 Acute liver failure Auxiliary LT – During LT Recipient iliac
artery to graft
PV
Yes
Stange et al.
(2001)43
Settmacher et al.
(2003)21
53 HCC/hepatitis C
cirrhosis
DDLT Pre LT PVT During LT Recipient HA to
graft PV (with
calibration)
No
Stange et al.
(2001)43
Settmacher et al.
(2003)21
35 Budd–Chiari syndrome DDLT Pre-LT PVT During LT Recipient HA to
graft PV
No
Stange et al.
(2001)43
Settmacher et al.
(2003)21
55 Hepatitis B cirrhosis
retransplant
DDLT Pre LT PVT During LT Recipient aorta to
graft PV (with
calibration)
Yes
Charco et al.
(2001)22
66 Hepatitis C cirrhosis DDLT Pre-LT PVT Pre LT Recipient HA to
graft PV
No
Charco et al.
(2001)22
12 Biliary atresia DDLT Post-LT PVT 3 days after LT Recipient aorta to
graft PV
Yes
Ott et al. (2003)23 35 Alcoholic cirrhosis DDLT Post-LT PVT
requiring
emergency re-LT
5 weeks post LT Recipient aorta to
graft PV
Yes (donor
iliac artery)
Ott et al. (2003)23 57 Hepatitis B cirrhosis DDLT Post LT PVT
requiring
emergency re-LT
2 months after LT Recipient aorta to
graft PV
Yes (donor
iliac artery)
Ott et al. (2003)23 54 Hepatitis B cirrhosis DDLT Pre-LT PVT During LT Recipient HA to
PV
No
Ott et al. (2003)23 68 Hepatitis B cirrhosis DDLT Intraoperative
detection of PVT
During LT Recipient aorta to
graft PV
Yes (donor
iliac artery)
Nivatvongs et al.
(2004)24
70 Hepatitis C cirrhosis DDLT Pre-LT PVT During LT Recipient HA to
graft PV
No
Bonnet et al.
(2010)25
47 Alcoholic cirrhosis DDLT Pre-LT PVT During LT Recipient SA to
graft PV (with
calibration)
No
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Authors, year Age,
years
Postoperative course Survival outcomes Causes of death
PHT and other
complications
PVA thrombosis/
clinical presentation
Embolization or
ligature of the shunt
Erhard et al. (1995)19 29 Uneventful No No Alive at 10 months –
Erhard et al. (1995)19 47 PHT, acute renal
failure
No No Alive at 12 months –
Aspinall et al. (1996)26 53 Encephalopathy,
septicaemia
No No Died at 2 months Septic shock
Neelamekam et al.
(1997)20
55 Ascitis,
pseudoaneurysm
of PV
No No NA, alive –
Erhard et al. (1998)27 49 None No No Died at 17 days Septic shock
Erhard et al. (1998)27 18 None No No Alive at 12 months –
Erhard et al. (1998)27 25 None No No Died at 3 months CMV pneumonia
Erhard et al. (1998)27 20 None No No Alive at 10 months
(retransplanted)
–
Margarit et al. (2000)28 25 Renal failure NA No Alive at 6 months –
Stange et al. (2001)43
Settmacher et al.
(2003)21
53 None No No Alive at 36 months –
Stange et al. (2001)43
Settmacher et al.
(2003)21
35 Right heart failure No Elective coil
embolization of HA,
SA due to PHT (3
months)
Alive at 36 months –
Stange et al. (2001)43
Settmacher et al.
(2003)21
55 Biliary stricture No No Alive at 30 months –
Charco et al. (2001)22 66 Severe graft
dysfunction needing
retransplantation
No Emergency closure by
TAE due to PHT (14
months)
Alive at 24 months –
Charco et al. (2001)22 12 Bile leak NA Multi-organ failure Died at 4 months post
re-Tx
Multi-organ failure
Ott et al. (2003)23 35 Laparotomy for bile
leak, intra
abdominal bleeding
Yes, and PVT No Died at 2 months PVT and liver failure
Ott et al. (2003)23 57 Right heart failure,
acute renal failure
No No Died at 11 months HBV recurrence,
liver fibrosis
Ott et al. (2003)23 54 – NA No Alive at 36 months,
(retransplant for
chronic rejection)
–
Ott et al. (2003)23 68 Right heart failure,
ascites, recurrent
bleeding from
persisting
retroperitoneal
collaterals
NA No Died at 19 days Intra-abdominal
bleeding
Nivatvongs et al.
(2004)24
70 None NA No Alive at 20 months
(biliary stricture)
Bonnet et al. (2010)25 47 Diffuse aneurysmal
dilatation of portal
branches
No No Alive at 72 months
CMV, cytomegalovirus; DDLT, deceased donor liver transplant; GDA, gastroduodenal artery; HA, hepatic artery; HAT, hepatic artery thrombosis; HCC,
hepatocellular carcinoma; LT, liver transplant; NA, not available; PHT, portal hypertension; PV, portal vein; PVT, portal vein thrombosis; SA, splenic artery; TAE,
transarterial catheter embolization.
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retransplantation, which has better outcomes than emergency
re-LT. In five of the seven post-LT patients (71%) who underwent
salvage PVA in the emergency setting, PVA proved to be either
life- or graft-saving, either temporarily (as a bridge to retrans-
plantation) (n = 1) or for a prolonged period (n = 4).
In HPB surgery, in addition to HAT, one of the key indications
for PVA is the need for a salvage procedure in patients with HPB
cancers who require HA ligation or resection in order to ensure
curative surgery. In this context, the rationale for the procedure is
to provide inflow to a de-arterialized liver and to restore biliary
arterial flow through the arterioportal shunt in order to prevent
the occurrence of ischaemia-related biliary complications.14 Of
course, the potential risks and benefits must be balanced in such
patients before any major or extended resection is undertaken
with the aim of achieving cure. The option of preoperative selec-
tive embolization of the HA proper (distal to the origin of the
gastroduodenal artery) has been described in such patients.18 This
procedure is performed with the aim of facilitating the develop-
ment of arterial inflow collaterals to the liver from the diaphragm,
which will then compensate for the resected HA. However, this
strategy can be applied only in those patients in whom it is pos-
sible to leave the diaphragmatic attachments of the liver
untouched during the planned surgery (such as in a Whipple
pancreaticoduodenectomy that requires HA resection).
Literature review
As part of the present study, a literature search of the PubMed
database (1993–2012) using the key terms ‘de-arterialized
liver/arterioportal shunt/portal vein arterialization’ and ‘liver
transplantation/liver resection/pancreatic surgery/biliary surgery’
was performed. This exercise sought relevant studies on indica-
tions for and outcomes of PVA in LT and HPB surgery published
in English over the last two decades. Subsequently, the references
in the articles identified in the search were examined to identify
any further series of patients submitted to PVA. The use of PVA in
LT and HPB surgery was reported in 61 patients in 26 relevant
studies (excluding the present series of 16 patients) between 1993
and mid-2012, each of which referred to one to six patients.19–44
Studies that referred to those patients submitted to PVA and to
arterial reconstruction, in whom physiological arterial inflow was
thus maintained (25 patients in the LT setting and none in the
HPB setting) were excluded.19–28,43–45 In these patients, PVA was
used to optimize or augment portal inflow into the transplanted
liver in patients with either pre-LT PVT19–25 or post-LT PVT,19,22,26
or in the settings of auxiliary LT,22,27,28 paediatric LT,45 and acute
liver failure (Table 3).46 Portal vein arterialization has also been
described as an adjunct, in which HA reconstruction is indeed
performed after major liver resection, but PVA is added to
augment PV flow and to promote the regeneration of a small
remnant liver.47,48 The literature also includes a report of the use of
PVA in patients with anatomic variations such as the absence of
portal and mesenteric veins.45 These cases were also excluded.
Finally, a total of seven patients (19%) submitted to salvage PVA
in the LT setting (Table 4) and 29 (81%) patients submitted to
PVA in the HPB setting (Table 5) were identified.
All seven of the LT patients underwent emergency procedures
for HAT or massive HA arteriosclerosis precluding arterial recon-
struction detected during LT. Of the 29 patients submitted to
resectional surgery for diseases of the liver,biliary tract or pancreas,
24 underwent immediate PVA for curative surgery which necessi-
tated HA resection or ligation, or because of the non-visualization
of a good intrahepatic arterial signal intraoperatively, and five
patients underwent PVA for HAT or arterial ligation or rupture
with bleeding after resection.
An arterioportal shunt was feasible in all attempts. In the trans-
plant recipients, an arterioportal shunt was performed using the
HA to provide inflow in two patients (29%), themesenteric vessels
in four patients (57%), and the gastroduodenal artery in one
patient (14%). Among the 29 resected patients, the HA or
gastroduodenal artery was used in 17 patients (59%) and the
mesenteric arteries in 12 patients (41%).
The overall incidence of perioperative mortality was 14% (five
of 36 patients). Two patients died after an emergency PVA for
post-LT HAT. Three perioperative deaths occurred in the setting
of HPB surgery, involving one patient who died when emergency
PVA was performed for HA rupture and ligation, one who died
after emergency PVA performed because no intrahepatic arterial
flow was detected intraoperatively, and one patient who died fol-
lowing elective HA ligation and PVA for curative surgery. Death
was related to PVA thrombosis and acute renal failure in one
patient, to lung graft versus host disease (GVHD) and a
haematological disorder in one patient, to sepsis and multi-organ
failure in one patient, and to pulmonary oedema in one patient.
The cause was unknown in the remaining patient.
Overall, 20 patients (56%) were reported to remain alive at the
end of the respective study periods. Sixteen patients, including the
five who died perioperatively, were deceased. Eight patients died
late after hepatectomy as a result of tumour recurrence, one as a
result of sepsis and multi-organ failure after re-LT, and one as a
result of haemorrhagic shock secondary to severe PHT and
variceal bleed late after resection. In one patient the cause of death
was unknown.
Dealing with PHT and liver fibrosis
In the present series, complications related to PHT occurred in up
to 44% of patients submitted to PVA. To prevent PHT and its
related complications, some authors have suggested calibrating
the arterial inflow.25,37 Early experimental studies in dogs49 and
later clinical studies50 demonstrated the benefits of pressure- and
volume-controlled partial PVA on liver function and regenera-
tion. Shunt calibration is thought to preserve adequate portal
flow, yet to prevent PHT and hyperoxygenation of the liver. Chen
et al.37 reported the use of a silicon tube to restrict arterial flow to
prevent PHT in four patients in whom PVA was performed after
HA resection for hilar cholangiocarcinoma. No postoperative
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complications and no signs of PHT were observed in any patient
during the 1-year follow-up period.37 Another purported advan-
tage of calibrated PVA is that it prevents thrombosis from devel-
oping at the site of anastomosis as a result of the difference in
pressure between the artery and the PV (although this is uncom-
mon). Embolization of the shunt once adequate arterial collaterals
with hepatopetal flow have developed may also prevent PHT in
the long term.51
Experimental animal studies and clinical data have implicated
the prolonged ‘over-arterialization’ of portal blood flow in causing
hyperbilirubinaemia, liver fibrosis and progressive dilatation of
the intrahepatic portal branches, if the shunt does not close within
a few weeks.22,23,52 Animal experiment results demonstrated the
occurrence of structural changes in the liver parenchyma and
vessel tissue, such as necrotizing vasculitis, intimal fibrosis of the
PV and periportal fibrosis.52 Flow- and pressure-adapted PVA has
been shown in animal models to reduce these adverse effects and
to improve early graft function. These effects were not significant
when only the portal blood flow was reduced.49,50 Thus, arterial
calibration of the shunt or the use of smaller vessels may be
assumed to help by reducing portal pressure, while allowing a
satisfactory hepatic arterial inflow.
A practical approach to PVA
Thepotential problemsof PHTandpossible fibrosis after PVAraise
issues in relation to the calibrationof shunts to regulate the amount
of inflow, the choice of the site (inflow arterial vessel) at which the
PVA should ideally be performed, and the possible need for the
prophylactic closure of shunts after a certain period of time.
In the present study, prophylactic shunt calibration was not
used in any patient. Instead, as the study group’s concomitant
experience with caval inflow to the graft in transplantation indi-
cates, good results were achieved by the prophylactic eradication
of varices by pre-transplant sclerotherapy and band ligation.53 In
Table 4 Systematic review of reports analysing the outcomes of portal vein arterialization (PVA) in seven patients submitted to liver
transplantation
Authors, year Age,
years/sex
Liver transplantation Portal vein arterialization
Indication Primary surgery Indication for PVA
and timing
Type Interposed vein/
prosthetic graft used
Cavallari et al. (2001)39 40/M HBV and HCV cirrhosis DDLT HAT
(7 days)
Recipient HA to graft PV No
Shimizu et al. (2000)13 27/F Biliary atresia (post-Kasai) LDLT
(right lobe)
HAT
(during LT)
Arterioportal shunt in the
mesenteric vascular (MV)
branches
No
Maggi et al. (2010)40 52/M Alcoholic cirrhosis with HCC DDLT HAT (10 days) Recipient HA to PV No
Housari et al. (2011)41 66/F Acute liver failure DDLT Massive HA arteriosclerosis
(during LT)
Recipient GDA to graft PV No
Hayashi et al. (2012)42 1/M Post-BMT GVHD LDLT
(reduced LLS)
HAT
(10 days)
Arterioportal shunt in the MV
branches
No
Hayashi et al. (2012)42 19/M Biliary atresia post-Kasai LDLT
(left lobe)
HAT
(4 days)
Arterioportal shunt in the MV
branches
No
Hayashi et al. (2012)42 57/F HCV cirrhosis LDLT (right lobe) HAT
(9 days)
Arterioportal shunt in the MV
branches
No
Authors, year Age,
years/sex
Postoperative course Survival outcomes Cause of death
Significant complications PVA thrombosis/manner of
detection
Re-intervention
Cavallari et al. (2001)39 40/M None No No Died 3 months after re-LT
as a result of ischaemic
cholangitis
Multi-organ failure
and pneumonia
Shimizu et al. (2000)13 27/F None Yes, 1.5 months (hepatopetal
arterial collaterals)
No Alive at 14 months –
Maggi et al. (2010)40 52/M None No Retransplanted Alive at 16 months –
Housari et al. (2011)41 66/F Diffuse aneurysmal dilatation
of portal branches,
ischaemic cholangitis
No Re-LT for ischaemic
cholangitis
Alive at 9 months –
Hayashi et al. (2012)42 1/M Lung GVHD No No Died 12 days
after PVA
Lung GVHD with
haematologic
disorder
Hayashi et al. (2012)42 19/M Peritonitis, severe acute
cellular rejection
No No Died 43 days after PVA Sepsis
Hayashi et al. (2012)42 57/F Massive ascites, pleural
effusion (3 months)
No Surgical ligation of shunt
for to PHT symptoms
Alive –
BMT, bone marrow transplant; DDLT, deceased donor liver transplantation; F, female; GDA, gastroduodenal artery; GVHD, graft versus host disease; HA, hepatic artery; HAT, hepatic artery
thrombosis; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LT, liver transplant; LDLT, living donor liver transplant; LLS, left lateral segment; M, male; PHT,
portal hypertension; PV, portal vein.
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Table 5 Systematic review of reports analysing the outcomes of hepatopancreatobiliary (HPB) surgery with portal vein arterialization (PVA)
in 29 patients
Authors,
year
Age,
years/sex
HPB surgery Portal vein arterializations
Indication Primary surgery Indication Timing Type Interposed vein/
prosthetic graft
Ozeki et al.
(1997)29
NA NA LR For curative
surgery
During LR ICA to ICV No
Ozeki et al.
(1997)29
NA NA LR Inadequate
collateral
formation after
HA ligation
Post-LR ICA to ICV No
Ozeki et al.
(1997)29
NA NA LR For curative
surgery
During LR ICA to ICV No
Iseki et al.
(1998)30
64/M Hilar CC Extended left LR + PD
with RHA excision/
reconstruction
Post op HAT in
reconstructed
artery
1 day post LR Mesenteric
vascular
branches (ileal)
No
Iseki et al.
(1998)30
72/F Hilar CC Extended right LR Postoperative
ligation of CHA
following HAP
rupture (day 6)
causing massive
liver necrosis
7th day after
major
liver
resection
First PVA –
mesenteric
vascular
branches
(ileocaecal)
No
Iseki et al.
(1998)30
67/M Intrahepatic
CC
Extended left LR
(stenosis of right
and left HA post
intra-arterial
chemotherapy)
Stenosis of right
PV, branches
with massive
liver necrosis
1 day post LR Mesenteric
vascular
branches
(ileocaecal)
No
Iseki et al.
(1998)30
52/M Pancreatic
head cancer
PD, excision of CHA
and HAP, PV
resection/
reconstruction
For curative
surgery
(pre-emptive
shunt)
1 day before
major
resection
Mesenteric
vascular
branches
(jejunal)
No
Iseki et al.
(1998)30
68/M Gallbladder
cancer
PD, LR, excision of
HAP, CHA
For curative
surgery
During major
resection
Mesenteric
vascular
branches (ileal)
No
Iseki et al.
(1998)30
65/M Hilar CC PD, extended left LR,
excision of anterior
branch RHA
For curative
surgery
(pre-emptive
shunt)
5 days before
major
resection
Mesenteric
vascular
branches (ileal)
No
Tanabe et al.
(1999)31
53/M IHC Left extended LR Post op HAT
(pseudoaneurysm
with HA
stenosis) on
POD 6
9 days post
LR
Mesenteric
vascular
branches
No
Inoue et al.
(2000)32
NA Hilar CC Left extended LR with
HAP excision
Curative surgery During LR GDA to PV No
Kondo et al.
(2004)33
(n = 10)
56–81
(median
69)
Biliary cancer
(6 bile duct
and 4
gallbladder)
Major liver resection
with en bloc HA
resection
For curative
surgery
During LR GDA or CHA to
PV
No
Teramoto et al.
(2003)34
70/M Lower CBD CC PD HA embolization
(bleeding after
PD)
1 month Mesenteric
vascular
branches
No
Nakamura et al.
(2008)35
60/M Hilar liver
metastases
LR HA ligation 3 days Mesenteric
vascular
branches
No
Young et al.
(2008)36
54/M Hilar CC LR Curative During LR GDA to PV No
Young et al.
(2008)36
51/F Hilar CC LR Curative During LR RHA to PV No
Chen et al.
(2010)37
(n = 3)
50–54
(median
52)
Hilar CC LR Curative During LR HA to PV
(with calibration)
No
Qiu et al.
(2012)38
55/M Hilar CC LR Curative During LR GDA to PV No
734 HPB
HPB 2014, 16, 723–738 © 2013 International Hepato-Pancreato-Biliary Association
the post-PVA period, a strict surveillance protocol using upper GI
endoscopy was followed and patients with varices were managed
by prophylactic endoscopic band ligation.
Logically, all patients in whom PVA is performed should
undergo a preventive occlusion of the shunt in order to avoid
PHT-induced GI bleeding once collateral arterial pathways to the
liver have developed. In the current study, therapeutic shunt
embolization was performed in patients with signs of severe PHT
using interventional radiology (Fig. 3). In patients in whom this
was not possible, a non-absorbable ligature was placed surgically
around the arterial side to calibrate but not fully ligate the
arterioportal shunt.
In order to offset the potentially harmful consequences of PVA,
some technical modifications to these shunts are proposed.
1 It is preferable to use medium-sized arterial inflow vessels to
ensure good liver oxygenation in the first instance, to prevent
over-arterialization and to provide good short- and medium-
term patency.
2 If possible, choose an end vessel for arterial inflow so that using
this vessel for PVA will in no way compromise the arterial
supply of surrounding viscera. In the event that the shunt must
be embolized in the future, this will ensure that the blood
supply to the surrounding viscera is not compromised.
Authors, year Age,
years/sex
Postoperative course Survival outcomes Causes of death
PHT and other
significant
complications
PVA thrombosis/
clinical presentation
Closure of the shunt
Ozeki et al. (1997)29 NA None Yes, at 43 days No NA/alive –
Ozeki et al. (1997)29 NA None NA No In-hospital death Pulmonary oedema
Ozeki et al. (1997)29 NA None No No NA/alive –
Iseki et al. (1998)30 64/M None No No Died at 4 months Recurrence
Iseki et al. (1998)30 72/F None Yes, day 2, requiring
new PVA
(SA to PV with
interposition femoral
vein graft)
No In-hospital death
at 8 days
Reperfusion injury
leading to acute
renal failure
Iseki et al. (1998)30 67/M None Yes, day 2 No Died at 11 months Recurrence
Iseki et al. (1998)30 52/M Hyperbilirubinaemia/
right liver abscess
No No Died at 6 months Recurrence
Iseki et al. (1998)30 68/M Hyperbilirubinaemia No Elective by TAE
(11 months)
Alive at 60 months –
Iseki et al. (1998)30 65/M Hyperbilirubinaemia No Elective by TAE
(8 months)
Alive at 30 months Recurrence
Tanabe et al. (1999)31 53/M None Yes, 20 days No NA, alive –
Inoue et al. (2000)32 NA None No No Alive at 1 month –
Kondo et al. (2004)33
(n = 10)
56–81
(median
69)
Bile leak (n = 2)
Liver abscess (n = 1)
Yes, n = 3 Elective shunt closure
(n = 7) after
documenting
collaterals
Four died at 1, 11,
21, 23 months
Six alive at a median
of 10 months
Recurrence in 3
cases, unknown
cause in 1.
Teramoto et al.
(2003)34
70/M Liver abscess NA No Alive at 69 days –
Nakamura et al.
(2008)35
60/M Variceal bleeding No Emergency closure
for PHT
Died at 4 months Haemorrhagic
shock
Young et al. (2008)36 54/M Hyperbilirubinaemia No No Died at 23 months Recurrence
Young et al. (2008)36 51/F Bile leak,
intra-abdominal
bleed, PV
pseudoaneurysm
No Emergency closure
for intra-abdominal
bleed (12 days)
Alive at 6 months –
Chen et al. (2010)37
(n = 3)
50–54
(median
52)
None No No One patient died
at 7 months
Liver abscess,
pneumonia
Qiu et al. (2012)38 55/M Hyperbilirubinaemia No No Alive at 12 months –
CC, cholangiocarcinoma; CBD, common bile duct; CHA, common hepatic artery; F, female; GDA, gastroduodenal artery; HA, hepatic artery; HAP, hepatic artery
proper; HAT, hepatic artery thrombosis; ICA, ileocolic artery; ICV, ileocolic vein; IHC, intrahepatic cholangiocarcinoma; LR, liver resection; M, male; NA, not
available; PD, pancreaticoduodenectomy; PHT, portal hypertension; PV, portal vein; RHA, right hepatic artery; SA, splenic artery; TAE, transarterial embolization.
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3 The choice of abdominal incision and the choice of the site of
the arterioportal shunt are also dictated to some extent by the
context in which PVA is to be performed (LT or HPB surgery,
emergency or elective). In LT recipients, particularly with late
HAT, a midline incision may be preferred to avoid abdominal
adhesions, and a PVA between the iliac artery or its branches
and the mesenteric vein or its tributaries with or without the
use of a jump graft may be created. Themain goal of PVA in this
context is to serve as a bridge to re-LT and thus the hilum can be
left untouched. Further, dissection of the graft hilar structures is
difficult and sometimes impossible, and may even prove dan-
gerous in patients who have undergone previous surgery or
have extensive variceal collaterals often associated with HAT or
PVT. Ease of access for the possible future embolization of the
shunt is also a consideration.
In the setting of liver resection, the main goal of PVA is to
restore the biliary arterial supply in the remnant liver. The policy
of the present group is to perform, if possible, an anastomosis
between the HA and PV.When the HA is thrombosed, or the HA
stump is too small or when the stump lies deep in the hilum, PVA
can be performed using the SA or mesenteric arterial branches as
the arterial inflow vessel.
There is no published literature or experimental data to dem-
onstrate the time interval required for irreversible biliary ischae-
mia to occur after HA interruption. However, the consequences of
HAT in a totally de-arterialized liver aremuchmore severe as there
are no collaterals with which to salvage the bile ducts. As Mays
and Wheeler54 have demonstrated, selective arteriography shows
retrohepatic arterial flow as early as 10 h after the interruption of
hepatic arteries. Therefore, if high-quality MDCT does not show
good collaterals with hepatic inflow, PVA should be undertaken as
early as possible in order to avoid irreversible biliary ischaemia.
The present group does not consider PVA in patients with late
HAT in whom biliary ischaemia is already evident. Instead, these
patients are considered to be candidates for re-LT once concurrent
sepsis (which is inevitable in these cases) is controlled.
Conclusions
For now, PVA should continue to be considered as a salvage tech-
nique to restore arterial inflow to a totally de-arterialized liver
when no other form of arterial reconstruction is possible. The
procedure prevents the occurrence of hepatic necrosis, which is
inevitable following complete arterial interruption, and in some
instances, such as in patients with HAT after LT, acts as a bridge to
retransplantation, which can then be performed electively, with
better results. In locally advanced malignancies of the liver, biliary
tract and pancreas, PVA may help to increase the possibility of a
curative (R0) resection in patients who are otherwise deemed
inoperable. Although these ‘extreme surgeries’, like ex situ, ex vivo
resections, carry a higher risk for perioperative mortality, they
may be justified in young patients with advanced malignancies
who otherwise will have very grim prognoses. Similarly, PVA may
also represent the last option in emergency situations such as in
intraoperative injury to the HA, post-resection HAT or arterial
rupture, when no other form of arterial reconstruction is feasible.
Strict surveillance and management of PHT (and its complica-
tions), and the occasional occlusion of the arterioportal shunt are
vital after PVA to prevent or manage life-threatening bleeding.
Indeed, these factors are key to reducing perioperative or delayed
mortality. Early thrombosis of the PVA may lead to fatal liver
ischaemia, whereas a late occlusion is often well tolerated because
of the prior development of hepatopetal arterial collaterals.
Despite its applicability, feasibility, theoretical appeal and
acceptable outcomes, many unanswered questions discourage the
liberal use of salvage PVA. Portal vein arterialization remains an
infrequently used surgical technique, and larger series with longer
follow-up, as well as experimental models on liver regeneration
after PVA, are required to provide greater insight into the out-
comes of this technique.
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